Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Michael Kennah"'
Autor:
Natasha Kekre, Kevin A. Hay, John R. Webb, Ranjeeta Mallick, Miruna Balasundaram, Mhairi K. Sigrist, Anne-Marie Clement, Julie S. Nielsen, Jennifer Quizi, Eric Yung, Scott D. Brown, Lisa Dreolini, Daniel D. Waller, Julian Smazynski, Nicole S. Gierc, Bianca C. Loveless, Kayla Clark, Tyler Dyer, Richard Hogg, Leah McCormick, Michael Gignac, Shanti Bell, D. Maria Chapman, David Bond, Siao Yong, Rachel Fung, Heather M. Lockyer, Victoria Hodgson, Catherine Murphy, Ana Subramanian, Evelyn Wiebe, Piriya Yoganathan, Liana Medynski, Dominique C. Vaillan, Alice Black, Sheryl McDiarmid, Michael Kennah, Linda Hamelin, Kevin Song, Sujaatha Narayanan, Judith A. Rodrigo, Stefany Dupont, Terry Hawrysh, Justin Presseau, Kednapa Thavorn, Manoj M. Lalu, Dean A. Fergusson, John C. Bell, Harold Atkins, Brad H. Nelson, Robert A. Holt
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Access to commercial CD19 CAR-T cells remains limited even in wealthy countries like Canada due to clinical, logistical, and financial barriers related to centrally manufactured products. We created a non-commercial academic platform for end-to-end m
Externí odkaz:
https://doaj.org/article/ba9bb5ccb69a4646aee78f29aa8e0137
Autor:
Michael Kennah, Natasha Kekre
Publikováno v:
Handbook of Stem Cell Transplantation and Cellular Therapy Management
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::87dacfd35bf8527731217621578c5427
https://doi.org/10.1891/9780826139948.0014
https://doi.org/10.1891/9780826139948.0014
Autor:
Kelsey Maclellan, Michael Kennah, Sathish Kumar Gopalakrishnan, Harold L. Atkins, Mitchell Sabloff, Sultan Altouri, Mohamad Sobh, Elizabeth Drouin, Lothar Huebsch, Ranjeeta Mallick, David S. Allan, Pierre Villeneuve, Grace Christou, Natasha Kekre, Christopher Bredeson, Jill Fulcher, Alexandre P. Blanchard, Sita D. Bhella, Nicole B. Laferriere
Publikováno v:
Blood. 134:3263-3263
Introduction: With the improvement in transplant practices during recent years, non-relapse mortality (NRM) following allogeneic hematopoietic cell transplantation (allo-HCT) has significantly improved. The use of reduced intensity conditioning has e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5aad467d07d13fc3a79b85ac4b18a152
https://doi.org/10.1182/blood-2019-122436
https://doi.org/10.1182/blood-2019-122436
Autor:
Michael Kennah, Alice L.-F. Mui, Christopher J. Ong, Tien Yin Yau, Gerald Krystal, Matt Nodwell, Raymond J. Andersen
Publikováno v:
Experimental hematology. 37(11)
Objective Multiple myeloma (MM) is a B-lymphocyte neoplasia that is presently incurable because the tumor cells become resistant to currently available drugs. The growth and survival signals resulting from interactions between the malignant clones an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a4e1cd00575da1caec15595cfd003b4
https://pubmed.ncbi.nlm.nih.gov/19703514
https://pubmed.ncbi.nlm.nih.gov/19703514
Autor:
Michael Kennah, Suzanne Trudel, Rodger E. Tiedemann, Esther Masih-Khan, Vishal Kukreti, Donna E. Reece, Nastaran Noroozi, Tony Panzarella, Christine Chen
Publikováno v:
Blood. 124:2019-2019
Introduction With routine use of autologous stem cell transplantation (ASCT) and novel agents, survival of patients with multiple myeloma (MM) has improved in recent years. Yet, MM remains incurable and long-term survivors (LTS) of ≥10 years from d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c7bb882b28c7ea2d2f767e1ae3a5fdf0
https://doi.org/10.1182/blood.v124.21.2019.2019
https://doi.org/10.1182/blood.v124.21.2019.2019